View attachment 569362
Chart of TSLA
View attachment 569364
Chart of QQQ
Friday's trading of TSLA saw a dip of some 9.5% shortly after market open. I suspect there were big players who prevented the dip from touching 10% and thus they avoided the alternate uptick rule for short-selling to come into effect for two days. Once a profit-taking dip at the top of a huge run begins, it develops a momentum that can cause trading such as Friday's as people's expectations about call options are readjusted and shares are sold to unwind some of the delta-hedging put in place to cover those call options are short-term enough to likely not come into the money. Algos see the selling and join in the selling to ride the trend. Nervous investors take some money off the table. We've all seen this movie multiple times.
I had to do a double-take when comparing TSLA's chart to QQQ's chart above. They look remarkably similar. The big difference, however, is that TSLA closed down over 6% while the NASDAQ closed down less than 1% on Friday. The two days TSLA trading with negative macros strikes me as a combination of manipulations where needed, and a tendency for profit taking as well as traders playing the dip. Let's look at all these kinds of sellers.
Some profit taking and consolidation is good for the stock after a long climb
I know this sounds like a doctor telling you that athlete's foot or gout is actually good for you, but hear me out. A profit-taking dip is a form of consolidation in which investors with lower convictions at that price are selling to investors with higher convictions at that price. Once that transfer of shares is completed, the stock is ready to resume its climb. Here are some examples:
Bull profit-takers: Take me for instance. I am extremely bullish on TSLA for 2020, but I sold enough shares and leaps last Monday to buy my 2nd home. I now have taken enough money off the table that I can comfortably leave the rest in with high conviction. Once you exceed your retirement goal by 3X or 4X, you have to ask yourself, "Do I want my life to resemble Jimmy Buffet's or Warren Buffet's?" For me, the choice was the former, but I'm keeping the majority of my Tesla investment intact because of strong conviction.
Weak longs: If a Tesla investor feels that the downside is bigger than the upside, chances are that investor's time horizon is pretty short. He will sell to someone with a longer time horizon who is comfortable with the stock in the 1400s because the new investor believes this stock is going up enough in the mid-to-long run to justify the purchase. The new investor is far more likely to ride out volatility.
Traders: These investors really should be lumped with weak longs. They lack long-term conviction and are only in shares or call options because TSLA is "the hot stock" and has been going up. The stock price dips as they bail, but someone better picks up those shares.
Dip players: These investors know that TSLA is volatile and once it starts down it may run down for a while. They sell when they see the downward trend and plan to rebuy once TSLA has "bottomed out." The problem is that if there are too many dip players doing the same trade, there's too much competition for buying when TSLA starts up again, and the price can run uphill remarkably quickly, often removing the option to make money by the play.
Anyway, it's healthy to get through a consolidating, profit-taking dip after a long run because most investors are expecting one. The mindset of the market will be more positive after the profit-taking and consolidation dip is completed. Call options will become more affordable.
Why Q3 is likely going to be great
With Fremont installing new general assembly lines and with Shanghai coming closer to achieving design production rate for Model 3, the production numbers for Q3 2020 are going to be massive, something over 140,000. Moreover, the best way to quickly come up to speed on the implications of the Q2 ER is to watch
this video by Rob Maurer, his first of 2 about the Q2 ER. Rob's biggest takeaway from the ER was that Gross Margins are going to be strong in the future. Thus, you combine improving gross margins with significantly higher deliveries and you should see record profits. Add September's Battery Day and a likely S&P500 inclusion surprise to the quarter and it looks just too good to pass on. On Monday we get to see how close the two parties are on putting together Stimulus 4. It's going to happen and will give the macros the necessary kick. For all these reasons, I am riding out the recent dip and look forward to riding this stock higher as Q3 shows the world what it has to offer.
Coronavirus
Along with China tensions, Coronavirus is weighing heavily on the market right now. Check out the chart below, taken Sunday evening.
View attachment 569366
Much angst has developed from the second wave of COVID 19 in the U.S., but as the chart above shows, the second wave may have already peaked. Fingers crossed. Moreover, California, Texas, and Florida, the three most watched states right now, all showed declines in new cases. The market should be happy.
One of my biggest frustrations with the coronavirus response in the U.S. has been the lack of timely studies of potential therapies. The retroactive Chloroquine and zinc study that showed a possible reduction of deaths by 80% has been stuck in peer review for weeks now. Maybe something significant has been found and maybe not, but the pacing of getting these studies out there has been dismal. Fortunately, the CDC
in this article says that they're going to be conducting many scientifically sound studies immediately on a variety of coronavirus therapies.
One new therapeutic that needs to be looked at seriously in the U.S. is one made by Synairgen, a small British biotech company. Shares soared on the company as a study
in this article suggests that taking this inhaled formula of the protein interferon beta "reduced the odds of a patient developing severe disease by 79%."
With positive developments in COVID 19 and progress toward Stimulus 4, futures were up Sunday evening as this post was written.
View attachment 569365
While Thursday's trading was a return to the 1500 plateau, another day of dismal macros led to TSLA testing the mid bollinger band and then bouncing. If you look at the other instances of touching the Mid-bb in the chart below, you'll see intraday excursions below the mid-bb but closing always seemed to be above. With any luck, Friday's bounce will be our beginning of a price recovery.
For the week, TSLA closed at 1417.00, down 83.84 from last Friday's 1500.84. It's been a wild week with an intraday ATH of nearly 1800 on Monday, an excellent ER on Wednesday, a Moody's upgrade, tons of price target upgrades, and two stinker trading days on bad macros. Better days lay ahead.
Conditions:
* Dow down 182 (0.68%)
* NASDAQ down 98 (0.94%)
* TSLA 1417.00, down 96.07 (6.35%)
* TSLA volume 19.4M shares
* Oil 41.14
* Percent of TSLA selling tagged to shorts: 39.8%